MIRA Pharmaceuticals (MIRA) Institutional Ownership $0.94 -0.13 (-12.25%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.90 -0.04 (-4.57%) As of 04/17/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for MIRA Pharmaceuticals (NASDAQ:MIRA)CurrentInstitutional OwnershipPercentage35.16%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$888.03KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$99.54K Get MIRA Insider Trade Alerts Want to know when executives and insiders are buying or selling MIRA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MIRA Institutional Buying and Selling by Quarter MIRA Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Two Sigma Investments LP24,317$28K0.0%N/A0.147% 2/17/2025Citadel Advisors LLC97,976$112K0.0%N/A0.592% 2/14/2025Northern Trust Corp30,362$35K0.0%+50.9%0.183% 2/13/2025Renaissance Technologies LLC45,772$52K0.0%N/A0.276% 2/11/2025Virtu Financial LLC63,410$72K0.0%N/A0.383% 2/3/2025Suncoast Equity Management22,644$26K0.0%-74.8%0.137% 1/8/2025International Assets Investment Management LLC25,000$29K0.0%N/A0.151% 10/23/2024Cross Staff Investments Inc365,901$476K0.4%-4.6%2.475% 10/21/2024Suncoast Equity Management90,000$117K0.0%+125.0%0.609% 5/20/2024Virtu Financial LLC63,055$69K0.0%+330.2%0.427% 5/2/2024Suncoast Equity Management40,000$44K0.0%N/A0.271% 5/2/2024Cross Staff Investments Inc383,401$422K0.4%N/A2.594% 4/10/2024 Praetorian Wealth Management Inc.27,500$30K0.0%N/A0.186% (Data available from 1/1/2016 forward) MIRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MIRA shares? During the previous two years, 9 institutional investors and hedge funds held shares of MIRA Pharmaceuticals. The most heavily invested institutionals were Cross Staff Investments Inc ($476K), Citadel Advisors LLC ($112K), Virtu Financial LLC ($72K), Renaissance Technologies LLC ($52K), Northern Trust Corp ($35K), Praetorian Wealth Management Inc. ($30K), and International Assets Investment Management LLC ($29K).Learn more on MIRA's institutional investors. What percentage of MIRA Pharmaceuticals stock is owned by institutional investors? 35.16% of MIRA Pharmaceuticals stock is owned by institutional investors. Learn more on MIRA's institutional investor holdings. Which institutional investors have been buying MIRA Pharmaceuticals stock? Of the 9 institutional investors that purchased MIRA Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Cross Staff Investments Inc ($383.40K), Virtu Financial LLC ($111.81K), Citadel Advisors LLC ($97.98K), Suncoast Equity Management ($90K), Renaissance Technologies LLC ($45.77K), Praetorian Wealth Management Inc. ($27.50K), and International Assets Investment Management LLC ($25K). How much institutional buying is happening at MIRA Pharmaceuticals? Institutional investors have bought a total of 816,011 shares in the last 24 months. This purchase volume represents approximately $918.28K in transactions. Which MIRA Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold MIRA Pharmaceuticals stock in the last 24 months: Suncoast Equity Management ($67.36K), and Cross Staff Investments Inc ($17.50K). How much institutional selling is happening at MIRA Pharmaceuticals? Institutional investors have sold a total of 84,856 shares in the last 24 months. This volume of shares sold represents approximately $99.54K in transactions. Related Companies Quince Therapeutics Institutional Ownership Jasper Therapeutics Institutional Ownership Metagenomi Institutional Ownership Medicus Pharma Institutional Ownership Citius Oncology Institutional Ownership I-Mab Institutional Ownership PMV Pharmaceuticals Institutional Ownership Ikena Oncology Institutional Ownership vTv Therapeutics Institutional Ownership Immuneering Institutional Ownership This page (NASDAQ:MIRA) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
